Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic MMSCs for Hematopoietic Recovery and Enterocolitis Prophylaxis in Lymphoma
NCT02145923Phase 2Unknown
- Sponsor
- Burnasyan Federal Medical Biophysical Center
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived mesenchymal stromal cells in neutropenic enterocolitis (NEC), bone marrow aplasia, sponsored by Burnasyan Federal Medical Biophysical Center. Status: unknown.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
neutropenic enterocolitis (NEC)bone marrow aplasia
Beyond the preview
Go deeper on NCT02145923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145923.